CYCLOSERINE

CYCLOSERINE was reported 2317 times

CYCLOSERINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BENIGN SOFT TISSUE NEOPLASM 7 0.1842
1 ACID FAST STAIN POSITIVE 2 0.1429
2 DELUSIONAL DISORDER, MIXED TYPE 2 0.1250
3 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 14 0.0769
4 CATHETER SITE HYPERSENSITIVITY 3 0.0750
5 ERYTHROBLAST COUNT 1 0.0714
6 TOXIC OPTIC NEUROPATHY 31 0.0714
7 PYOPNEUMOTHORAX 4 0.0656
8 AIDS RELATED COMPLICATION 4 0.0615
9 HYPERALBUMINAEMIA 4 0.0488
10 CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE 2 0.0476
11 POLYNEUROPATHY CHRONIC 3 0.0441
12 FEMALE REPRODUCTIVE NEOPLASM 2 0.0408
13 PERICARDITIS TUBERCULOUS 4 0.0400
14 TYPE 1 LEPRA REACTION 2 0.0392
15 NICOTINIC ACID DEFICIENCY 4 0.0360
16 INJECTION SITE VASCULITIS 2 0.0351
17 SIDEROBLASTIC ANAEMIA 4 0.0286
18 INTRACARDIAC MASS 5 0.0282
19 AUDIOGRAM ABNORMAL 1 0.0250
20 HYPNOPOMPIC HALLUCINATION 3 0.0242
21 VENTRICULAR DYSKINESIA 5 0.0240
22 DYSDIADOCHOKINESIS 4 0.0234
23 PORTAL FIBROSIS 5 0.0234
24 ELECTROCARDIOGRAM T WAVE ALTERNANS 1 0.0233
25 CYTOKINE INCREASED 3 0.0222
26 DELUSION OF REFERENCE 3 0.0216
27 CYSTIC LUNG DISEASE 3 0.0211
28 HEPATITIS B ANTIGEN POSITIVE 1 0.0208
29 OPTIC NEUROPATHY 43 0.0203
30 SECONDARY HYPOTHYROIDISM 3 0.0196
31 CORNEAL PIGMENTATION 1 0.0175
32 PNEUMONECTOMY 3 0.0171
33 TRICHOGLOSSIA 7 0.0171
34 ACROPHOBIA 1 0.0167
35 ERYTHROBLAST COUNT INCREASED 1 0.0167
36 BULLOUS IMPETIGO 1 0.0167
37 PYELONEPHRITIS CHRONIC 3 0.0160
38 PANCREATIC CALCIFICATION 2 0.0154
39 CARDIAC NEOPLASM UNSPECIFIED 3 0.0150
40 OTOTOXICITY 26 0.0140
41 TERATOMA 3 0.0140
42 BONE TUBERCULOSIS 5 0.0131
43 CEREBRAL MICROANGIOPATHY 3 0.0126
44 HEPATITIS D 1 0.0119
45 HYPERINTENSITY IN BRAIN DEEP NUCLEI 1 0.0119
46 HEPATITIS C RNA INCREASED 4 0.0117
47 BASAL GANGLIA INFARCTION 4 0.0116
48 TYPE 2 LEPRA REACTION 2 0.0107
49 GASTRIC ULCER HELICOBACTER 1 0.0105
50 CONNECTIVE TISSUE INFLAMMATION 1 0.0105
51 ELECTROCARDIOGRAM U-WAVE ABNORMALITY 1 0.0102
52 TOXIC NEUROPATHY 4 0.0102
53 LIPOMATOSIS 2 0.0101
54 GLOMERULONEPHRITIS ACUTE 2 0.0097
55 MYCOBACTERIUM TEST POSITIVE 2 0.0097
56 ATROPHIC GLOSSITIS 1 0.0092
57 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 7 0.0090
58 MENINGITIS TUBERCULOUS 5 0.0089
59 HYPERALDOSTERONISM 3 0.0087
60 MITOCHONDRIAL TOXICITY 7 0.0085
61 HAEMOPHILIC ARTHROPATHY 2 0.0084
62 PULMONARY TUBERCULOSIS 35 0.0082
63 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
64 ELECTROCARDIOGRAM QT PROLONGED 291 0.0081
65 PULMONARY RESECTION 2 0.0081
66 BALANITIS CANDIDA 1 0.0078
67 DISSEMINATED TUBERCULOSIS 20 0.0078
68 FIBROMA 7 0.0076
69 PATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0075
70 DEPOSIT EYE 2 0.0075
71 OROPHARYNGEAL PLAQUE 3 0.0074
72 COAGULATION FACTOR DECREASED 2 0.0073
73 CELL-MEDIATED IMMUNE DEFICIENCY 1 0.0071
74 DERMATOPHYTOSIS 2 0.0070
75 BETA 2 MICROGLOBULIN URINE INCREASED 1 0.0070
76 DYSMETRIA 4 0.0066
77 WOLFF-PARKINSON-WHITE SYNDROME 3 0.0064
78 CONGENITAL GENITAL MALFORMATION 1 0.0063
79 HAEMATOLOGY TEST ABNORMAL 2 0.0062
80 OPTIC NEURITIS 56 0.0062
81 BLOOD ALDOSTERONE INCREASED 1 0.0057
82 VESTIBULAR DISORDER 7 0.0057
83 FALSE NEGATIVE INVESTIGATION RESULT 4 0.0057
84 DRUG RESISTANCE MUTATION 1 0.0056
85 EYE SYMPTOM 2 0.0056
86 HYPERLACTACIDAEMIA 15 0.0056
87 BLOOD MAGNESIUM INCREASED 5 0.0055
88 MULTIPLE-DRUG RESISTANCE 17 0.0055
89 GRANDIOSITY 2 0.0055
90 GRANULOMATOUS LYMPHADENITIS 1 0.0053
91 COR PULMONALE CHRONIC 1 0.0053
92 BRONCHOPLEURAL FISTULA 2 0.0053
93 MEDIASTINAL MASS 2 0.0052
94 GAMMA-GLUTAMYLTRANSFERASE DECREASED 1 0.0052
95 HEPATOTOXICITY 114 0.0051
96 BRACHYDACTYLY 1 0.0051
97 ANTISOCIAL BEHAVIOUR 5 0.0050
98 HEPATITIS TOXIC 13 0.0050
99 HEPATORENAL FAILURE 3 0.0050
100 TRICHOSPORON INFECTION 2 0.0049
101 SPUTUM CULTURE POSITIVE 4 0.0049
102 BURN INFECTION 1 0.0049
103 LEPROSY 1 0.0048
104 DRUG RESISTANCE 122 0.0047
105 CORONA VIRUS INFECTION 2 0.0047
106 HEPATIC RUPTURE 1 0.0045
107 HYPERURICAEMIA 18 0.0044
108 FOREARM FRACTURE 3 0.0043
109 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
110 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 2 0.0043
111 ALLODYNIA 5 0.0043
112 TUBERCULOUS PLEURISY 2 0.0042
113 MYCOBACTERIUM ABSCESSUS INFECTION 3 0.0042
114 VITAMIN B COMPLEX DEFICIENCY 3 0.0040
115 NORMOCHROMIC NORMOCYTIC ANAEMIA 12 0.0040
116 BURNING FEET SYNDROME 1 0.0040
117 WHITE MATTER LESION 5 0.0040
118 DEAFNESS NEUROSENSORY 13 0.0039
119 BUTTERFLY RASH 4 0.0039
120 INFECTIOUS PLEURAL EFFUSION 6 0.0039
121 ADJUSTMENT DISORDER 5 0.0038
122 ELECTROCARDIOGRAM T WAVE ABNORMAL 6 0.0038
123 INADEQUATE DIET 2 0.0038
124 HYPEREOSINOPHILIC SYNDROME 2 0.0037
125 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 1 0.0037
126 CARDIOPULMONARY FAILURE 14 0.0036
127 BLOOD GROWTH HORMONE INCREASED 2 0.0036
128 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
129 BILE ACID MALABSORPTION 1 0.0035
130 DIABETIC GANGRENE 1 0.0035
131 AGITATED DEPRESSION 1 0.0035
132 AXONAL NEUROPATHY 3 0.0034
133 PERIPHERAL NERVE INJURY 3 0.0034
134 EXTRAPULMONARY TUBERCULOSIS 1 0.0034
135 ASPIRATION BRONCHIAL 1 0.0034
136 CYANOPSIA 2 0.0033
137 LONG QT SYNDROME 8 0.0033
138 ENTEROCOLITIS VIRAL 1 0.0033
139 PSOAS ABSCESS 2 0.0032
140 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
141 ASOCIAL BEHAVIOUR 1 0.0031
142 PERIPHERAL SENSORY NEUROPATHY 18 0.0031
143 DIABETIC HYPERGLYCAEMIC COMA 1 0.0031
144 HYPERCREATINAEMIA 1 0.0030
145 POST PROCEDURAL DISCHARGE 2 0.0030
146 STENOTROPHOMONAS INFECTION 4 0.0029
147 URETHRAL STENOSIS 2 0.0029
148 TORTICOLLIS 6 0.0028
149 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 72 0.0028
150 COMPLICATIONS OF TRANSPLANTED LIVER 1 0.0028
151 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 3 0.0027
152 LYMPH NODE TUBERCULOSIS 2 0.0027
153 BILE DUCT STENT INSERTION 1 0.0026
154 QRS AXIS ABNORMAL 2 0.0026
155 CAPILLARY DISORDER 1 0.0026
156 EXTRADURAL ABSCESS 2 0.0025
157 NEUROPATHY PERIPHERAL 242 0.0025
158 INTRACRANIAL PRESSURE INCREASED 14 0.0025
159 OPTIC NERVE DISORDER 4 0.0025
160 CLUBBING 1 0.0025
161 ACUTE PSYCHOSIS 6 0.0024
162 PATHOGEN RESISTANCE 22 0.0024
163 HYDROTHORAX 2 0.0024
164 CEREBELLAR INFARCTION 4 0.0024
165 IMMUNE RECONSTITUTION SYNDROME 3 0.0023
166 PATERNAL EXPOSURE DURING PREGNANCY 2 0.0023
167 LENTICULAR OPACITIES 1 0.0023
168 GRAFT VERSUS HOST DISEASE IN SKIN 5 0.0023
169 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
170 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
171 OROPHARYNGEAL CANDIDIASIS 2 0.0022
172 PROTEIN URINE 2 0.0022
173 BONE INFARCTION 1 0.0022
174 LICHENOID KERATOSIS 5 0.0022
175 COLOUR BLINDNESS 2 0.0022
176 PNEUMONIA KLEBSIELLA 4 0.0022
177 ECZEMA HERPETICUM 1 0.0022
178 EATING DISORDER SYMPTOM 1 0.0022
179 CEREBRAL TOXOPLASMOSIS 2 0.0021
180 GASTRIC VARICES 1 0.0021
181 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
182 ARTERIOVENOUS FISTULA 1 0.0020
183 HEPATITIS FULMINANT 6 0.0020
184 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
185 DRUG-INDUCED LIVER INJURY 63 0.0020
186 POLYNEUROPATHY 24 0.0020
187 BLOOD CHLORIDE DECREASED 5 0.0019
188 ACQUIRED IMMUNODEFICIENCY SYNDROME 1 0.0019
189 HYPERLIPASAEMIA 1 0.0019
190 OPHTHALMOPLEGIA 3 0.0019
191 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
192 OPTIC ATROPHY 3 0.0018
193 PITUITARY TUMOUR BENIGN 3 0.0018
194 BRONCHOSTENOSIS 1 0.0018
195 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9 0.0018
196 TOXIC ENCEPHALOPATHY 9 0.0018
197 NEUROPATHY 3 0.0018
198 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
199 ELECTROLYTE IMBALANCE 20 0.0017
200 HEPATITIS C VIRUS TEST POSITIVE 1 0.0017
201 ADRENAL ADENOMA 1 0.0017
202 DYSPLASIA 2 0.0017
203 CHRONIC RESPIRATORY FAILURE 2 0.0017
204 FEBRILE CONVULSION 2 0.0016
205 PARADOXICAL DRUG REACTION 6 0.0016
206 BLOOD BILIRUBIN DECREASED 1 0.0016
207 HEPATOBILIARY DISEASE 1 0.0016
208 HYPOPROTEINAEMIA 3 0.0016
209 DRY GANGRENE 1 0.0016
210 SINUS ARRHYTHMIA 2 0.0015
211 ALCOHOL POISONING 4 0.0015
212 PSYCHOTIC DISORDER 44 0.0015
213 POSTPARTUM HAEMORRHAGE 2 0.0015
214 HEAT ILLNESS 1 0.0015
215 CAPILLARY LEAK SYNDROME 3 0.0014
216 VIRAEMIA 2 0.0014
217 PROTHROMBIN TIME SHORTENED 2 0.0014
218 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
219 GRANULOMATOUS LIVER DISEASE 1 0.0014
220 ALCOHOL INTOLERANCE 1 0.0014
221 AUDITORY DISORDER 2 0.0014
222 BLOOD ELECTROLYTES DECREASED 2 0.0014
223 DYSHIDROTIC ECZEMA 1 0.0014
224 HYPOKALAEMIA 64 0.0014
225 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
226 RENAL INFARCT 2 0.0014
227 JUDGEMENT IMPAIRED 2 0.0014
228 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
229 VENTRICULAR ARRHYTHMIA 5 0.0014
230 LYMPHOPROLIFERATIVE DISORDER 4 0.0014
231 MYOCLONUS 16 0.0013
232 PELVIC INFLAMMATORY DISEASE 2 0.0013
233 PAPILLOEDEMA 6 0.0013
234 HEPATIC NECROSIS 5 0.0013
235 HIV INFECTION 4 0.0013
236 MARASMUS 2 0.0013
237 COMPLICATION OF PREGNANCY 1 0.0013
238 HYPOTHYROIDISM 42 0.0013
239 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
240 DENGUE FEVER 3 0.0013
241 COAGULATION TIME PROLONGED 2 0.0013
242 BILIRUBIN CONJUGATED INCREASED 3 0.0013
243 CRITICAL ILLNESS 1 0.0013
244 BREAST FEEDING 1 0.0013
245 DISTURBANCE IN SOCIAL BEHAVIOUR 3 0.0013
246 TINEA PEDIS 2 0.0013
247 BLOOD DISORDER 10 0.0012
248 NEPHROPATHY TOXIC 14 0.0012
249 ANAEMIA 236 0.0012
250 CRYPTOCOCCOSIS 2 0.0012
251 GIANT CELL ARTERITIS 1 0.0012
252 PERSECUTORY DELUSION 3 0.0012
253 NEUROTOXICITY 21 0.0012
254 AMAUROSIS 1 0.0012
255 DEAFNESS 31 0.0012
256 HEPATITIS A 1 0.0012
257 DEAFNESS BILATERAL 2 0.0012
258 HEPATOSPLENOMEGALY 3 0.0012
259 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
260 BLOOD CHLORIDE INCREASED 2 0.0012
261 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
262 OTORRHOEA 2 0.0011
263 TONGUE DISCOLOURATION 5 0.0011
264 MYELOSUPPRESSION 41 0.0011
265 HILAR LYMPHADENOPATHY 1 0.0011
266 ABDOMINAL SEPSIS 1 0.0011
267 HEPATITIS 29 0.0011
268 ANAEMIA OF CHRONIC DISEASE 1 0.0011
269 EXTENSOR PLANTAR RESPONSE 1 0.0011
270 PSYCHIATRIC SYMPTOM 8 0.0011
271 RETINOPATHY 4 0.0011
272 INTRACRANIAL MASS 1 0.0011
273 ASPARTATE AMINOTRANSFERASE INCREASED 56 0.0011
274 COR PULMONALE 1 0.0010
275 SUDDEN DEATH 11 0.0010
276 HYPOCOAGULABLE STATE 1 0.0010
277 BICYTOPENIA 2 0.0010
278 TOOTH DISCOLOURATION 3 0.0010
279 DUODENAL PERFORATION 1 0.0010
280 HYPOMAGNESAEMIA 14 0.0010
281 METABOLIC ENCEPHALOPATHY 3 0.0010
282 DILATED CARDIOMYOPATHY 1 0.0010
283 ORAL CANDIDIASIS 13 0.0010
284 PSYCHOTIC SYMPTOM 2 0.0010
285 MYOCARDIAL ISCHAEMIA 11 0.0010
286 MICROCYTIC ANAEMIA 2 0.0010
287 COGWHEEL RIGIDITY 1 0.0010
288 LANGUAGE DISORDER 2 0.0009
289 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0009
290 HEPATIC NEOPLASM 3 0.0009
291 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
292 HEPATITIS C 11 0.0009
293 TRANSAMINASES INCREASED 20 0.0009
294 HAEMOPTYSIS 25 0.0009
295 TOXIC SKIN ERUPTION 9 0.0009
296 TORSADE DE POINTES 7 0.0009
297 BRONCHIECTASIS 6 0.0009
298 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
299 GASTRIC POLYPS 2 0.0009
300 B-CELL LYMPHOMA 3 0.0009
301 LOW BIRTH WEIGHT BABY 7 0.0009
302 GRANULOMA 3 0.0009
303 VENTRICULAR EXTRASYSTOLES 9 0.0009
304 ARRHYTHMIA 41 0.0009
305 POLYMENORRHOEA 3 0.0009
306 HYPOPNOEA 3 0.0009
307 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0008
308 BONE MARROW FAILURE 17 0.0008
309 HYPOVOLAEMIC SHOCK 4 0.0008
310 INCORRECT PRODUCT ADMINISTRATION DURATION 18 0.0008
311 VISUAL FIELD DEFECT 6 0.0008
312 CARDIAC DEATH 1 0.0008
313 ENTEROCOCCAL INFECTION 4 0.0008
314 PANNICULITIS 2 0.0008
315 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
316 LACTIC ACIDOSIS 26 0.0008
317 DERMATITIS EXFOLIATIVE 4 0.0008
318 INTENTIONAL PRODUCT USE ISSUE 70 0.0008
319 HYPOCALCAEMIA 15 0.0008
320 DRUG ERUPTION 14 0.0008
321 ABORTION MISSED 1 0.0008
322 GLUCOSE URINE PRESENT 1 0.0008
323 DIABETIC COMPLICATION 2 0.0008
324 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
325 TINNITUS 36 0.0008
326 APGAR SCORE LOW 1 0.0008
327 HYPERBILIRUBINAEMIA 8 0.0008
328 RETINAL DISORDER 2 0.0008
329 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
330 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
331 BLOOD LACTIC ACID INCREASED 4 0.0008
332 LUNG OPACITY 2 0.0008
333 IRON DEFICIENCY ANAEMIA 7 0.0008
334 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
335 OESOPHAGEAL CANDIDIASIS 3 0.0008
336 CEREBRAL ATROPHY 3 0.0008
337 PANCYTOPENIA 42 0.0008
338 HEPATIC FUNCTION ABNORMAL 28 0.0007
339 LARYNGOSPASM 2 0.0007
340 GLYCOSURIA 1 0.0007
341 TREATMENT FAILURE 61 0.0007
342 EFFUSION 1 0.0007
343 DEMYELINATION 3 0.0007
344 NEPHROTIC SYNDROME 5 0.0007
345 BILIARY TRACT DISORDER 1 0.0007
346 ENCEPHALITIS 5 0.0007
347 VISUAL ACUITY REDUCED 24 0.0007
348 RASH MORBILLIFORM 2 0.0007
349 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
350 RESPIRATORY FAILURE 52 0.0007
351 OXYGEN SATURATION ABNORMAL 2 0.0007
352 PNEUMATOSIS INTESTINALIS 2 0.0007
353 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
354 BLOOD MAGNESIUM DECREASED 6 0.0007
355 ADENOVIRUS INFECTION 2 0.0007
356 EOSINOPHILIA 12 0.0007
357 GASTROINTESTINAL DISORDER 61 0.0007
358 DARK CIRCLES UNDER EYES 1 0.0007
359 FEELING DRUNK 5 0.0007
360 ILEUS PARALYTIC 3 0.0007
361 IRON DEFICIENCY 3 0.0007
362 DYSAESTHESIA 2 0.0007
363 CALCULUS URINARY 1 0.0006
364 GASTRITIS EROSIVE 3 0.0006
365 HYPOALBUMINAEMIA 5 0.0006
366 HEPATITIS E 1 0.0006
367 PNEUMOTHORAX 10 0.0006
368 PREMATURE DELIVERY 10 0.0006
369 JC VIRUS INFECTION 1 0.0006
370 GASTROENTERITIS 9 0.0006
371 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
372 HEPATOMEGALY 6 0.0006
373 CARDIOMYOPATHY 9 0.0006
374 HYPERAESTHESIA 5 0.0006
375 BRADYARRHYTHMIA 1 0.0006
376 PEPTIC ULCER 2 0.0006
377 CYTOLYTIC HEPATITIS 2 0.0006
378 HYPERNATRAEMIA 3 0.0006
379 EOSINOPHIL COUNT INCREASED 5 0.0006
380 LEUKOPENIA 30 0.0006
381 MENINGITIS 4 0.0006
382 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
383 KLEBSIELLA INFECTION 3 0.0006
384 DRUG TOLERANCE 3 0.0006
385 HEPATORENAL SYNDROME 1 0.0006
386 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
387 EROSIVE OESOPHAGITIS 1 0.0006
388 FOOD AVERSION 1 0.0006
389 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
390 FACIAL PARALYSIS 5 0.0006
391 TREATMENT NONCOMPLIANCE 32 0.0006
392 APLASIA PURE RED CELL 2 0.0006
393 HALLUCINATION, VISUAL 12 0.0006
394 DEPRESSIVE SYMPTOM 2 0.0006
395 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
396 BREAST CYST 1 0.0006
397 HEPATIC FAILURE 17 0.0006
398 CARDIOTOXICITY 5 0.0006
399 DERMATITIS ALLERGIC 7 0.0006
400 THROMBOCYTOPENIA 62 0.0006
401 INTESTINAL ISCHAEMIA 3 0.0005
402 ABORTION INCOMPLETE 1 0.0005
403 HYPERTENSIVE HEART DISEASE 1 0.0005
404 GASTRITIS 14 0.0005
405 PREMATURE LABOUR 3 0.0005
406 BLOOD BICARBONATE DECREASED 1 0.0005
407 GRANULOCYTOPENIA 3 0.0005
408 MYOCARDITIS 6 0.0005
409 LIPASE INCREASED 4 0.0005
410 HYPOREFLEXIA 1 0.0005
411 ENTEROCOLITIS 3 0.0005
412 BLOOD URIC ACID INCREASED 3 0.0005
413 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
414 BLOOD BILIRUBIN INCREASED 14 0.0005
415 SINUS BRADYCARDIA 5 0.0005
416 METABOLIC DISORDER 3 0.0005
417 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
418 SPINAL CORD COMPRESSION 2 0.0005
419 THROMBOTIC MICROANGIOPATHY 5 0.0005
420 RESPIRATORY DISTRESS 14 0.0005
421 GENE MUTATION 1 0.0005
422 EXPOSURE VIA BREAST MILK 2 0.0005
423 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
424 DEVICE RELATED SEPSIS 1 0.0005
425 HAEMOGLOBIN DECREASED 51 0.0005
426 VITAMIN B12 DEFICIENCY 2 0.0005
427 HEPATOCELLULAR INJURY 7 0.0005
428 PIGMENTATION DISORDER 3 0.0005
429 IMPAIRED SELF-CARE 1 0.0005
430 MENTAL DISORDER 21 0.0005
431 SUICIDAL BEHAVIOUR 2 0.0005
432 PHOTOPHOBIA 9 0.0005
433 LATENT TUBERCULOSIS 1 0.0005
434 HALLUCINATIONS, MIXED 2 0.0005
435 EAR SWELLING 1 0.0005
436 BUNDLE BRANCH BLOCK LEFT 2 0.0005
437 SKIN HYPERPIGMENTATION 4 0.0005
438 HEPATITIS ACUTE 3 0.0005
439 OCULAR ICTERUS 2 0.0005
440 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
441 OSTEONECROSIS 15 0.0005
442 CHOLECYSTITIS CHRONIC 3 0.0004
443 CALCINOSIS 1 0.0004
444 MALNUTRITION 5 0.0004
445 BLOOD CALCIUM DECREASED 5 0.0004
446 CHRONIC GASTRITIS 1 0.0004
447 TACHYPNOEA 6 0.0004
448 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
449 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
450 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
451 VAGINAL INFECTION 2 0.0004
452 BRONCHOSPASM 6 0.0004
453 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
454 NON-SMALL CELL LUNG CANCER 2 0.0004
455 ACUTE RESPIRATORY FAILURE 8 0.0004
456 AFFECT LABILITY 4 0.0004
457 ATELECTASIS 4 0.0004
458 LIVER FUNCTION TEST ABNORMAL 12 0.0004
459 HEART INJURY 1 0.0004
460 PROTEIN URINE PRESENT 2 0.0004
461 HEPATIC ENZYME INCREASED 27 0.0004
462 BRAIN ABSCESS 1 0.0004
463 HYPOACUSIS 17 0.0004
464 ENDOCARDITIS 2 0.0004
465 CACHEXIA 2 0.0004
466 EXPOSURE DURING PREGNANCY 24 0.0004
467 BLOOD ALBUMIN DECREASED 3 0.0004
468 ATRIAL FLUTTER 3 0.0004
469 METABOLIC ACIDOSIS 12 0.0004
470 BLOOD POTASSIUM ABNORMAL 1 0.0004
471 ABDOMINAL MASS 1 0.0004
472 HEPATIC CIRRHOSIS 7 0.0004
473 VOMITING 175 0.0004
474 PRODUCT PRESCRIBING ISSUE 8 0.0004
475 HYDROCEPHALUS 2 0.0004
476 LIVER INJURY 9 0.0004
477 PREMATURE BABY 11 0.0004
478 DEAFNESS UNILATERAL 2 0.0004
479 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
480 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
481 NECROSIS 2 0.0004
482 BLOOD UREA INCREASED 6 0.0004
483 CHOLECYSTITIS ACUTE 2 0.0004
484 DRUG INTOLERANCE 34 0.0004
485 NEUTROPHILIA 2 0.0004
486 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
487 DYSPNOEA AT REST 1 0.0003
488 RENAL IMPAIRMENT 29 0.0003
489 URINE OUTPUT DECREASED 3 0.0003
490 HYPERKALAEMIA 12 0.0003
491 HYPERTRIGLYCERIDAEMIA 2 0.0003
492 PRODUCT COMMUNICATION ISSUE 3 0.0003
493 SEIZURE 39 0.0003
494 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
495 PULMONARY HYPERTENSION 7 0.0003
496 CREPITATIONS 1 0.0003
497 ATYPICAL PNEUMONIA 1 0.0003
498 BLOOD POTASSIUM DECREASED 10 0.0003
499 HYPERCAPNIA 1 0.0003
500 HEPATITIS CHOLESTATIC 2 0.0003
501 HEPATITIS B 2 0.0003
502 CENTRAL VENOUS CATHETERISATION 1 0.0003
503 DYSCHEZIA 1 0.0003
504 OFF LABEL USE 284 0.0003
505 DIASTOLIC DYSFUNCTION 1 0.0003
506 TENDONITIS 5 0.0003
507 OLIGURIA 2 0.0003
508 DELUSION 5 0.0003
509 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
510 BLOOD CREATININE DECREASED 1 0.0003
511 PLATELET COUNT DECREASED 34 0.0003
512 BLOOD SODIUM DECREASED 6 0.0003
513 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
514 HAEMATOTOXICITY 3 0.0003
515 HEPATITIS B REACTIVATION 1 0.0003
516 CUSHINGOID 1 0.0003
517 PRODUCT USE IN UNAPPROVED INDICATION 77 0.0003
518 BLOOD POTASSIUM INCREASED 5 0.0003
519 TENDON DISORDER 2 0.0003
520 BLOOD CREATININE INCREASED 20 0.0003
521 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
522 SHOCK 7 0.0003
523 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
524 EXPOSURE DURING BREAST FEEDING 1 0.0003
525 DECREASED APPETITE 70 0.0003
526 CARDIAC FAILURE ACUTE 2 0.0003
527 ANXIETY DISORDER 1 0.0003
528 CARDIAC FAILURE 24 0.0003
529 EMPHYSEMA 3 0.0003
530 DRUG LEVEL DECREASED 3 0.0003
531 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
532 HEPATIC FIBROSIS 1 0.0003
533 LEFT VENTRICULAR FAILURE 1 0.0003
534 DEPRESSION SUICIDAL 1 0.0003
535 ACUTE KIDNEY INJURY 44 0.0003
536 HYPERREFLEXIA 1 0.0003
537 EXTRASYSTOLES 2 0.0003
538 ENCEPHALOPATHY 7 0.0003
539 JOINT DISLOCATION 3 0.0003
540 ADVERSE EVENT 26 0.0003
541 EATING DISORDER 6 0.0003
542 SINUS TACHYCARDIA 4 0.0003
543 HAEMORRHAGIC DIATHESIS 1 0.0003
544 LIVER FUNCTION TEST INCREASED 6 0.0003
545 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
546 MYELODYSPLASTIC SYNDROME 4 0.0003
547 HYPERTHYROIDISM 4 0.0003
548 HYPOAESTHESIA 41 0.0003
549 BLOOD PHOSPHORUS DECREASED 1 0.0003
550 HYPOMANIA 1 0.0003
551 BACTERIAL INFECTION 5 0.0003
552 HYDRONEPHROSIS 2 0.0003
553 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
554 AUTOIMMUNE THYROIDITIS 1 0.0003
555 HAEMATURIA 9 0.0003
556 HYPERTHERMIA 2 0.0003
557 THYROID DISORDER 4 0.0003
558 DRUG INTERACTION 41 0.0003
559 CONGENITAL ANOMALY 2 0.0003
560 CAESAREAN SECTION 3 0.0003
561 SPLENOMEGALY 3 0.0003
562 EPIGASTRIC DISCOMFORT 1 0.0003
563 PULMONARY HAEMORRHAGE 2 0.0003
564 SEPTIC SHOCK 11 0.0003
565 BACTERAEMIA 3 0.0003
566 HALLUCINATION, AUDITORY 4 0.0003
567 ABSCESS 4 0.0003
568 AZOTAEMIA 1 0.0003
569 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
570 BLEPHARITIS 1 0.0002
571 CANDIDIASIS 1 0.0002
572 SENSORY DISTURBANCE 4 0.0002
573 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
574 INTENTIONAL SELF-INJURY 5 0.0002
575 SHOCK HAEMORRHAGIC 2 0.0002
576 ASPHYXIA 2 0.0002
577 GOITRE 1 0.0002
578 NEUTROPENIA 33 0.0002
579 GENERALISED OEDEMA 3 0.0002
580 SKIN DISCOLOURATION 11 0.0002
581 MOUTH ULCERATION 5 0.0002
582 HYPERPYREXIA 1 0.0002
583 CARDIAC FAILURE CHRONIC 1 0.0002
584 ANURIA 2 0.0002
585 DELIRIUM 8 0.0002
586 PLATELET COUNT INCREASED 3 0.0002
587 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
588 EPILEPSY 7 0.0002
589 ABNORMAL BEHAVIOUR 9 0.0002
590 LUNG INFILTRATION 2 0.0002
591 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
592 MYOSITIS 2 0.0002
593 PARAESTHESIA 35 0.0002
594 ANAL INCONTINENCE 2 0.0002
595 UVEITIS 3 0.0002
596 PULMONARY EMBOLISM 21 0.0002
597 NEUTROPHIL COUNT DECREASED 9 0.0002
598 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
599 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
600 ISCHAEMIA 1 0.0002
601 GRAND MAL CONVULSION 2 0.0002
602 ASTHENIA 81 0.0002
603 HEPATIC ENCEPHALOPATHY 2 0.0002
604 APPENDICITIS 2 0.0002
605 PLEURAL EFFUSION 13 0.0002
606 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
607 HYPONATRAEMIA 12 0.0002
608 SKIN REACTION 3 0.0002
609 ABORTION INDUCED 2 0.0002
610 CARDIAC TAMPONADE 1 0.0002
611 ANGINA PECTORIS 6 0.0002
612 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
613 ORAL HERPES 4 0.0002
614 DYSPEPSIA 20 0.0002
615 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
616 LIVER DISORDER 9 0.0002
617 BREATH SOUNDS ABNORMAL 1 0.0002
618 HOSPICE CARE 2 0.0002
619 ABDOMINAL TENDERNESS 1 0.0002
620 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
621 DYSPHORIA 1 0.0002
622 HAEMATEMESIS 5 0.0002
623 SUICIDAL IDEATION 18 0.0002
624 HYPOPHAGIA 5 0.0002
625 TEMPERATURE INTOLERANCE 2 0.0002
626 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
627 FOETAL DEATH 1 0.0002
628 ACUTE MYELOID LEUKAEMIA 3 0.0002
629 NAUSEA 152 0.0002
630 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
631 APLASTIC ANAEMIA 1 0.0002
632 RESTLESSNESS 7 0.0002
633 FOLLICULITIS 2 0.0002
634 DISEASE RECURRENCE 9 0.0002
635 FEAR 5 0.0002
636 HALLUCINATION 14 0.0002
637 BEHAVIOUR DISORDER 1 0.0002
638 PNEUMONITIS 5 0.0002
639 FAECALOMA 1 0.0002
640 PYREXIA 63 0.0002
641 ASTHENOPIA 1 0.0002
642 HYPERKERATOSIS 1 0.0002
643 PRODUCT USE ISSUE 34 0.0002
644 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
645 SKIN DISORDER 6 0.0002
646 AGGRESSION 9 0.0002
647 HYPERTENSIVE CRISIS 2 0.0002
648 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
649 THERAPY NON-RESPONDER 8 0.0002
650 PANCREATITIS ACUTE 4 0.0002
651 TOXICITY TO VARIOUS AGENTS 30 0.0002
652 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
653 RED BLOOD CELL COUNT DECREASED 5 0.0002
654 HYPERTONIA 1 0.0002
655 PERICARDIAL EFFUSION 4 0.0002
656 DEPRESSION 39 0.0002
657 ARTHRALGIA 71 0.0002
658 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
659 ASCITES 5 0.0002
660 HYPERCHLORHYDRIA 1 0.0002
661 VISUAL IMPAIRMENT 21 0.0002
662 TACHYCARDIA 15 0.0002
663 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
664 GANGRENE 1 0.0002
665 OSTEOMYELITIS 3 0.0002
666 ADRENAL INSUFFICIENCY 2 0.0002
667 HYPERGLYCAEMIA 6 0.0002
668 DERMATITIS ACNEIFORM 1 0.0002
669 CYTOPENIA 2 0.0002
670 HYPERCALCAEMIA 2 0.0002
671 NERVOUS SYSTEM DISORDER 5 0.0002
672 PNEUMONIA ASPIRATION 4 0.0002
673 SYNCOPE 16 0.0002
674 CELLULITIS 8 0.0002
675 BRAIN OEDEMA 2 0.0002
676 PROTEINURIA 3 0.0002
677 CARDIOVASCULAR DISORDER 4 0.0002
678 HIATUS HERNIA 2 0.0002
679 HYPERPROLACTINAEMIA 1 0.0002
680 HAEMORRHOIDS 3 0.0002
681 PALPITATIONS 18 0.0002
682 BRADYPHRENIA 1 0.0002
683 SEPSIS 17 0.0002
684 HYPOGAMMAGLOBULINAEMIA 1 0.0002
685 BEDRIDDEN 2 0.0002
686 IMMUNE SYSTEM DISORDER 2 0.0002
687 CORONAVIRUS INFECTION 1 0.0002
688 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
689 ADVERSE REACTION 2 0.0002
690 TREMOR 25 0.0002
691 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
692 FULL BLOOD COUNT DECREASED 3 0.0001
693 SUICIDE ATTEMPT 9 0.0001
694 LOSS OF CONSCIOUSNESS 19 0.0001
695 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
696 OEDEMA 8 0.0001
697 DRUG TOXICITY 2 0.0001
698 IMPAIRED GASTRIC EMPTYING 2 0.0001
699 DYSPNOEA 83 0.0001
700 INSOMNIA 39 0.0001
701 PERIPHERAL COLDNESS 2 0.0001
702 CARDIAC ARREST 12 0.0001
703 JOINT EFFUSION 1 0.0001
704 DROOLING 1 0.0001
705 DERMATITIS 3 0.0001
706 SLEEP DISORDER 10 0.0001
707 LYMPHOPENIA 2 0.0001
708 CHEST PAIN 26 0.0001
709 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
710 VISION BLURRED 19 0.0001
711 FAECES DISCOLOURED 3 0.0001
712 CEREBRAL DISORDER 1 0.0001
713 STEVENS-JOHNSON SYNDROME 3 0.0001
714 RASH MACULO-PAPULAR 3 0.0001
715 RENAL INJURY 4 0.0001
716 HEPATOCELLULAR CARCINOMA 1 0.0001
717 HAEMOLYSIS 1 0.0001
718 ATRIOVENTRICULAR BLOCK 1 0.0001
719 CONCUSSION 1 0.0001
720 APNOEA 1 0.0001
721 AFFECTIVE DISORDER 1 0.0001
722 ARTHRITIS 10 0.0001
723 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
724 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
725 GINGIVAL PAIN 1 0.0001
726 RASH ERYTHEMATOUS 6 0.0001
727 DIABETIC KETOACIDOSIS 3 0.0001
728 COUGH 35 0.0001
729 HYPOGLYCAEMIA 6 0.0001
730 NEURALGIA 3 0.0001
731 CEREBRAL INFARCTION 3 0.0001
732 DECUBITUS ULCER 1 0.0001
733 BLINDNESS 5 0.0001
734 CONDITION AGGRAVATED 37 0.0001
735 ACUTE CORONARY SYNDROME 1 0.0001
736 EMBOLISM 1 0.0001
737 ABDOMINAL PAIN 28 0.0001
738 CYTOMEGALOVIRUS INFECTION 2 0.0001
739 AGEUSIA 3 0.0001
740 RHABDOMYOLYSIS 5 0.0001
741 HYPOTENSION 24 0.0001
742 HAEMODIALYSIS 1 0.0001
743 CHRONIC KIDNEY DISEASE 9 0.0001
744 PARANOIA 2 0.0001
745 MULTI-ORGAN FAILURE 2 0.0001
746 DIPLOPIA 3 0.0001
747 VERTIGO 7 0.0001
748 MUCOSAL INFLAMMATION 3 0.0001
749 BURNING SENSATION 8 0.0001
750 HYPERSENSITIVITY 21 0.0001
751 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
752 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
753 ISCHAEMIC STROKE 2 0.0001
754 THIRST 2 0.0001
755 HAEMARTHROSIS 1 0.0001
756 GASTROINTESTINAL INFECTION 1 0.0001
757 GOUT 2 0.0001
758 RASH PRURITIC 6 0.0001
759 TOOTHACHE 2 0.0001
760 PALLOR 3 0.0001
761 GASTROINTESTINAL CARCINOMA 1 0.0001
762 DISEASE PROGRESSION 13 0.0001
763 DYSURIA 4 0.0001
764 DEEP VEIN THROMBOSIS 7 0.0001
765 FLANK PAIN 1 0.0001
766 DYSARTHRIA 4 0.0001
767 DYSPNOEA EXERTIONAL 4 0.0001
768 INTESTINAL OBSTRUCTION 4 0.0001
769 RENAL FAILURE 14 0.0001
770 PULMONARY FIBROSIS 2 0.0001
771 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
772 GLAUCOMA 2 0.0001
773 HYPERCHOLESTEROLAEMIA 1 0.0001
774 DIZZINESS POSTURAL 1 0.0001
775 EAR PAIN 2 0.0001
776 CHOKING 2 0.0001
777 INFLAMMATORY BOWEL DISEASE 1 0.0001
778 LUNG DISORDER 5 0.0001
779 DISORIENTATION 4 0.0001
780 RASH 44 0.0001
781 HAEMATOCRIT DECREASED 2 0.0001
782 CATARACT 6 0.0001
783 CORONARY ARTERY DISEASE 3 0.0001
784 PRURITUS 38 0.0001
785 DEATH 85 0.0001
786 BODY TEMPERATURE INCREASED 2 0.0001
787 EUPHORIC MOOD 1 0.0001
788 INITIAL INSOMNIA 1 0.0001
789 MYOCARDIAL INFARCTION 17 0.0001
790 EAR DISCOMFORT 1 0.0001
791 GYNAECOMASTIA 3 0.0001
792 EYE DISCHARGE 1 0.0001
793 DIZZINESS 48 0.0001
794 ROAD TRAFFIC ACCIDENT 4 0.0001
795 PANCREATITIS 5 0.0001
796 DIARRHOEA 61 0.0001
797 HYPERTENSION 20 0.0001
798 POOR QUALITY SLEEP 2 0.0001
799 DECREASED ACTIVITY 1 0.0001
800 PRURITUS GENERALISED 2 0.0001
801 ASPIRATION 1 0.0001
802 MELAENA 2 0.0001
803 OEDEMA PERIPHERAL 11 0.0001
804 FUNGAL INFECTION 3 0.0001
805 DEHYDRATION 12 0.0001
806 CHROMATURIA 2 0.0001
807 IMPAIRED DRIVING ABILITY 1 0.0001
808 HEADACHE 55 0.0001
809 GASTRIC DISORDER 3 0.0001
810 GASTRIC HAEMORRHAGE 1 0.0001
811 MUSCLE TWITCHING 2 0.0001
812 RASH MACULAR 3 0.0001
813 HYPOXIA 3 0.0001
814 LYMPHADENOPATHY 3 0.0001
815 ANXIETY 24 0.0001
816 DYSPHAGIA 8 0.0001
817 ATAXIA 1 0.0001
818 COMPLETED SUICIDE 7 0.0001
819 PRODUCTIVE COUGH 4 0.0001
820 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
821 IRRITABILITY 5 0.0001
822 INTERSTITIAL LUNG DISEASE 4 0.0001
823 CRYING 3 0.0001
824 MENTAL IMPAIRMENT 2 0.0001
825 ACCIDENTAL OVERDOSE 3 0.0001
826 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
827 PNEUMONIA 26 0.0001
828 ACNE 6 0.0001
829 INTRAOCULAR PRESSURE INCREASED 1 0.0001
830 ADVERSE DRUG REACTION 7 0.0001
831 ERECTILE DYSFUNCTION 2 0.0001
832 SPEECH DISORDER 4 0.0001
833 DEPRESSED MOOD 4 0.0001
834 ABORTION SPONTANEOUS 3 0.0001
835 HAIR TEXTURE ABNORMAL 1 0.0001
836 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
837 SOMNOLENCE 15 0.0001
838 JAUNDICE 2 0.0001
839 DYSKINESIA 3 0.0001
840 AKATHISIA 1 0.0001
841 SKIN LESION 2 0.0001
842 ABDOMINAL PAIN UPPER 15 0.0001
843 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
844 RESPIRATORY ARREST 2 0.0001
845 MENTAL STATUS CHANGES 2 0.0001
846 POLLAKIURIA 3 0.0001
847 HUNGER 1 0.0001
848 COORDINATION ABNORMAL 1 0.0001
849 APHONIA 1 0.0001
850 ABDOMINAL DISCOMFORT 12 0.0001
851 PERIPHERAL SWELLING 11 0.0001
852 BLOOD TEST ABNORMAL 1 0.0001
853 MYALGIA 12 0.0001
854 MUSCULAR WEAKNESS 8 0.0001
855 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
856 CONVULSION 4 0.0001
857 CARDIOGENIC SHOCK 1 0.0001
858 LETHARGY 4 0.0001
859 HYPOKINESIA 1 0.0001
860 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
861 APATHY 1 0.0001
862 URINARY INCONTINENCE 2 0.0001
863 COLON CANCER 1 0.0001
864 PULMONARY OEDEMA 3 0.0001
865 HAEMORRHAGE INTRACRANIAL 1 0.0001
866 RESPIRATORY DISORDER 2 0.0001
867 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
868 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
869 ILL-DEFINED DISORDER 4 0.0001
870 EJECTION FRACTION DECREASED 1 0.0001
871 CONSTIPATION 14 0.0001
872 CARDIAC DISORDER 6 0.0001
873 PAIN IN EXTREMITY 18 0.0001
874 WEIGHT DECREASED 17 0.0001
875 DRUG LEVEL INCREASED 1 0.0001
876 BLOOD PRESSURE DECREASED 4 0.0001
877 VIRAL INFECTION 2 0.0001
878 TYPE 2 DIABETES MELLITUS 2 0.0001
879 FACE OEDEMA 1 0.0001
880 HEMIPARESIS 1 0.0001
881 CIRCULATORY COLLAPSE 1 0.0001
882 ABDOMINAL DISTENSION 6 0.0001
883 MUSCULOSKELETAL PAIN 3 0.0001
884 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
885 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
886 MOBILITY DECREASED 4 0.0001
887 BONE DISORDER 1 0.0001
888 AGITATION 4 0.0001
889 AGRANULOCYTOSIS 1 0.0001
890 URTICARIA 9 0.0001
891 ERYTHEMA 11 0.0001
892 SWELLING 5 0.0001
893 OXYGEN SATURATION DECREASED 3 0.0001
894 COLITIS 2 0.0001
895 GASTRIC ULCER 1 0.0001
896 GAIT DISTURBANCE 10 0.0001
897 HERPES ZOSTER 3 0.0001
898 DYSTONIA 1 0.0001
899 BLOOD PRESSURE ABNORMAL 1 0.0001
900 THERAPEUTIC RESPONSE DECREASED 3 0.0000
901 FEEDING DISORDER 1 0.0000
902 DRY MOUTH 4 0.0000
903 DISCOMFORT 3 0.0000
904 CARDIO-RESPIRATORY ARREST 2 0.0000
905 AMNESIA 3 0.0000
906 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
907 HOSPITALISATION 7 0.0000
908 ANGIOEDEMA 2 0.0000
909 GLOSSODYNIA 1 0.0000
910 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
911 MALAISE 19 0.0000
912 CONFUSIONAL STATE 7 0.0000
913 RENAL DISORDER 2 0.0000
914 BLOOD CHOLESTEROL INCREASED 2 0.0000
915 COGNITIVE DISORDER 2 0.0000
916 OVERDOSE 9 0.0000
917 BLOOD GLUCOSE DECREASED 2 0.0000
918 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
919 JOINT SWELLING 5 0.0000
920 UNDERDOSE 3 0.0000
921 EXTRAPYRAMIDAL DISORDER 1 0.0000
922 DRUG INEFFECTIVE 53 0.0000
923 DRY EYE 2 0.0000
924 INCORRECT DOSE ADMINISTERED 9 0.0000
925 DIABETES MELLITUS 3 0.0000
926 BLOOD PRESSURE INCREASED 6 0.0000
927 CHEST DISCOMFORT 4 0.0000
928 ANAPHYLACTIC SHOCK 1 0.0000
929 HAEMORRHAGE 4 0.0000
930 BRADYCARDIA 2 0.0000
931 CARDIAC FAILURE CONGESTIVE 3 0.0000
932 FREQUENT BOWEL MOVEMENTS 1 0.0000
933 ANAPHYLACTIC REACTION 2 0.0000
934 MEDICATION ERROR 2 0.0000
935 NECK PAIN 2 0.0000
936 ALOPECIA 7 0.0000
937 BLISTER 2 0.0000
938 SKIN EXFOLIATION 3 0.0000
939 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
940 MUSCULOSKELETAL STIFFNESS 3 0.0000
941 DYSPHONIA 2 0.0000
942 ACUTE MYOCARDIAL INFARCTION 1 0.0000
943 FATIGUE 26 0.0000
944 OROPHARYNGEAL PAIN 3 0.0000
945 FEMUR FRACTURE 1 0.0000
946 HIP FRACTURE 1 0.0000
947 RHINORRHOEA 2 0.0000
948 SWELLING FACE 2 0.0000
949 PRODUCT DOSE OMISSION 2 0.0000
950 CHOLELITHIASIS 1 0.0000
951 EYE DISORDER 1 0.0000
952 BACK PAIN 7 0.0000
953 EYE PRURITUS 1 0.0000
954 ANGER 1 0.0000
955 CEREBROVASCULAR ACCIDENT 5 0.0000
956 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
957 HEART RATE DECREASED 1 0.0000
958 CEREBRAL HAEMORRHAGE 1 0.0000
959 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
960 C-REACTIVE PROTEIN INCREASED 1 0.0000
961 EYE SWELLING 1 0.0000
962 EXTRA DOSE ADMINISTERED 1 0.0000
963 BALANCE DISORDER 2 0.0000
964 INTENTIONAL PRODUCT MISUSE 2 0.0000
965 COVID-19 4 0.0000
966 PAIN 14 0.0000
967 BLOOD GLUCOSE INCREASED 4 0.0000
968 COMA 1 0.0000
969 INFECTION 3 0.0000
970 ATRIAL FIBRILLATION 2 0.0000
971 FLUSHING 2 0.0000
972 INFLAMMATION 1 0.0000
973 ECZEMA 1 0.0000
974 DERMATITIS ATOPIC 1 0.0000
975 ARTHROPATHY 1 0.0000
976 ASTHMA 2 0.0000
977 FLATULENCE 1 0.0000
978 URINARY TRACT INFECTION 3 0.0000
979 CHILLS 2 0.0000
980 INJECTION SITE PAIN 5 0.0000
981 NASOPHARYNGITIS 3 0.0000
982 INTENTIONAL OVERDOSE 1 0.0000
983 HYPERHIDROSIS 2 0.0000
984 DRY SKIN 2 0.0000
985 INJURY 1 0.0000
986 DYSGEUSIA 1 0.0000
987 WEIGHT INCREASED 3 0.0000
988 INFLUENZA LIKE ILLNESS 1 0.0000
989 DRUG DOSE OMISSION 2 0.0000
990 MUSCLE SPASMS 2 0.0000
991 HEART RATE INCREASED 1 0.0000
992 INFLUENZA 1 0.0000
993 INJECTION SITE ERYTHEMA 1 0.0000
994 FALL 2 0.0000